DUBLIN--(BUSINESS WIRE)--The "Global Antinuclear Antibody Tests Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025" report has been added to ResearchAndMarkets.com's offering.
The global antinuclear antibody tests market was valued at US$ 649 million in 2016, and is expected to reach US$ 1,588.7 million by 2025, expanding at a CAGR of 9.8% from 2017 to 2025
The global antinuclear antibody tests market is segmented by product type into reagent & assays kits, systems and software & services. Reagents and assay kits occupy the largest share of global antinuclear antibody tests market.
The global antinuclear antibody tests market is segmented by technique type into enzyme-linked immunosorbent assay (ELISA), immunofluorescence assay and multiplex assay. Enzyme-Linked Immunosorbent Assay (ELISA) dominates the global antinuclear antibody tests market.
By disease, global antinuclear antibody tests market is segmented into rheumatoid arthritis, systemic lupus erythematosus, Sjgren's syndrome, scleroderma and other diseases. Rheumatoid arthritis currently occupies the largest market share of global antibody tests market due to rising prevalence of rheumatoid arthritis.
Key Market Movements:
- Rising awareness about autoimmune disorders and availability of novel diagnostic tools and kits also contribute to the growth of antinuclear antibody tests market
- Prevalence of diagnosed autoimmune conditions is highest in EU-5 with 9%, followed by China and U.S. with 8% and 7% respectively. Autoimmune diseases is one of leading cause of mortality in developed countries. Thus rising prevalence of autoimmune disorder is the pivotal factor driving the growth of antinuclear antibody tests market
Key Topics Covered:
Chapter 1. Preface
Chapter 2. Executive Summary
Chapter 3. Antinuclear Antibody Tests: Market Dynamics and Future Outlook
Chapter 4. Global Antinuclear Antibody Tests Market, by Product Type, 2015 - 2025 (US$ Mn)
Chapter 5. Global Antinuclear Antibody Tests Market, by Technique Type, 2015 - 2025 (US$ Mn)
Chapter 6. Global Antinuclear Antibody Tests Market, by Disease Type, 2015 - 2025 (US$ Mn)
Chapter 7. Global Antinuclear Antibody Tests Market, by Geography, 2015 - 2025 (US$ Mn)
Chapter 8. Company Profiles
- Alere, Inc.
- Abbott Laboratories
- Antibodies, Inc.
- Bio-Rad Laboratories, Inc.
- Biocom Biotech
- Erba Diagnostics, Inc.
- Euroimmun AG
- HUMAN Diagnostics, Inc.
- Immuno Concepts, Inc.
- Inova Diagnostics, Inc.
- Thermo Fisher Scientific, Inc.
- Trinity Biotech Plc
- Zeus Scientific, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/h9rj3d/global_1_58?w=4